DGX
Quest Diagnostics Incorporated
NYSE: DGX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$194.20
+2.58% today
Updated 2026-04-30
Market cap
$20.96B
P/E ratio
20.92
P/S ratio
1.86x
EPS (TTM)
$9.05
Dividend yield
1.67%
52W range
$162 – $213
Volume
0.9M
Quest Diagnostics Incorporated (DGX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
9.08%
Operating margin
14.20%
ROE
14.50%
ROA
6.35%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $6.27B | $586.42M | 41.04% | 17.99% | 9.35% |
| 2007 | $6.70B | $339.94M | 40.79% | 16.28% | 5.07% |
| 2008 | $7.25B | $581.50M | 41.29% | 16.86% | 8.02% |
| 2009 | $7.46B | $729.10M | 42.03% | 18.23% | 9.78% |
| 2010 | $7.37B | $720.90M | 41.41% | 17.58% | 9.78% |
| 2011 | $7.51B | $470.60M | 41.48% | 13.25% | 6.27% |
| 2012 | $7.38B | $555.70M | 40.88% | 16.27% | 7.53% |
| 2013 | $7.15B | $849.00M | 39.46% | 20.64% | 11.88% |
| 2014 | $7.43B | $556.00M | 37.63% | 13.22% | 7.48% |
| 2015 | $7.49B | $709.00M | 37.85% | 18.67% | 9.46% |
| 2016 | $7.51B | $645.00M | 38.58% | 16.99% | 8.58% |
| 2017 | $7.71B | $772.00M | 38.79% | 15.11% | 10.01% |
| 2018 | $7.53B | $736.00M | 34.59% | 14.62% | 9.77% |
| 2019 | $7.73B | $858.00M | 34.80% | 15.93% | 11.11% |
| 2020 | $9.44B | $1.43B | 38.50% | 20.89% | 15.16% |
| 2021 | $10.79B | $2.00B | 39.02% | 22.07% | 18.49% |
| 2022 | $9.88B | $946.00M | 34.74% | 14.45% | 9.57% |
| 2023 | $9.25B | $854.00M | 33.00% | 13.64% | 9.23% |
| 2024 | $9.87B | $871.00M | 32.86% | 13.63% | 8.82% |
| 2025 | $11.04B | $992.00M | 31.93% | 14.53% | 8.99% |